Author:
De Giorgi U,Rosti G,Zaniboni A,Ballardini M,Minzi M R,Baioni M,Ferrari E,Zornetta L,Marangolo M
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference30 articles.
1. Hortobagyi GN . Treatment of breast cancer. N Engl J Med 1998; 339: 974–984.
2. Pedrazzoli P, Perotti C, Da Prada GA et al. Collection of circulating progenitor cells after epirubicin, paclitaxel and filgrastim in patients with metastatic breast cancer. Br J Cancer 1997; 75: 1368–1372.
3. Zibera C, Pedrazzoli P, Ponchio L et al. An epirubicin/paclitaxel combination mobilizes large amounts of hematopoietic progenitor cells in patients with metastatic breast cancer showing optimal response to the same chemotherapy regimen. Haematologica 1999; 84: 924–929.
4. Bengala C, Pazzagli I, Tibaldi C et al. Mobilization, collection, and characterization of peripheral blood hemopoietic progenitors after chemotherapy with epirubicin, paclitaxel, and granulocyte-colony stimulating factor administered to patients with metastatic breast carcinoma. Cancer 1998; 82: 867–873.
5. Rosti G, Albertazzi L, Ferrante P et al. Epirubicin+G-CSF as peripheral blood progenitor cells (PBPC) mobilizing agents in breast cancer patients. Ann Oncol 1995; 6: 1045–1047.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献